EPRO Trademark

Trademark Overview

On Thursday, February 10, 2022, a trademark application was filed for EPRO with the United States Patent and Trademark Office. The USPTO has given the EPRO trademark a serial number of 97262202. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, August 7, 2025. This trademark is owned by AgeX Therapeutics, Inc.. The EPRO trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations and compositions for medical purposes, namely, preparations and compositions for lysing cancer cells based on the use of gene promoters
epro

General Information

Serial Number97262202
Word MarkEPRO
Filing DateThursday, February 10, 2022
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, August 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 26, 2025

Trademark Statements

Goods and ServicesChemical preparations and compositions for medical purposes, namely, preparations and compositions for lysing cancer cells based on the use of gene promoters

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 26, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgeX Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlameda, CA 94501

Trademark Events

Event DateEvent Description
Monday, February 14, 2022NEW APPLICATION ENTERED
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 23, 2022ASSIGNED TO EXAMINER
Friday, May 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 29, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 29, 2022NON-FINAL ACTION E-MAILED
Tuesday, November 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 28, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 28, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, December 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

epro compositions preparations cells based promoters cancer gene namely medical purposes